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Abstract A 31P nuclear magnetic resonance (NMR) study of
the interactions between oligonucleotides containing the (6-4)
photoproduct and the Fab fragments of monoclonal antibodies
(64M3 and 64M5) recognizing the (6-4) photoproduct is
reported. The 31P chemical shift data indicate that backbone
conformation of (6-4) adduct is affected by the presence of
flanking oligodeoxynucleotides, and (6-4) adducts with different
backbone conformations are accommodated in the antigen
binding sites of these antibodies. It was also revealed that
epitopes for these antibodies consist of not only the (6-4) adduct
but the flanking di- or tri-deoxynucleotides on both the 5P and 3P
sides as well.
z 1998 Federation of European Biochemical Societies.
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1. Introduction
DNA damage, which is caused by ultraviolet light (UV), in
cells leads to cell killing, mutation, and neoplastic transforma-
tion [1^3]. At adjacent pyrimidine sites, two major types of
photoproducts, i.e. cyclobutane pyrimidine dimers and pyri-
midine (6-4) pyrimidone photoproducts (Fig. 1), are formed.
It has been reported that the (6-4) photoproduct is less toler-
ated in cellular genomes during replication and much more
mutagenic than the cyclobutane dimer and therefore might
play a major role in UV-induced DNA lesions [4,5].
Polyclonal and monoclonal antibodies speci¢c to the cyclo-
butane or (6-4) photoproducts have been established to inves-
tigate the relationships between the generation of these UV-
induced DNA lesions and their biological e¡ects [6^13]. These
antibodies have also been used as probes to characterize the
conformations of isolated and duplex-embedded photoprod-
ucts [8,13]. In addition, it has been demonstrated that an anti-
body elicited against the trans, syn uracil cyclobutane dimer
hapten catalyzes the light-dependent cleavage of the uracil
dimer to normal dipyrimidine [14].
Nikaido and co-workers have established a variety of
monoclonal antibodies that speci¢cally bind to either cyclo-
butane or (6-4) pyrimidine dimers [9^11]. These monoclonal
antibodies were elicited by immunization with UV-irradiated
DNA, which is thought to contain heterogeneous antigenic
determining sites, and were characterized using DNA exposed
under controlled UV-irradiation conditions. These monoclo-
nal antibodies have been widely utilized for the detection and
quantitation of the DNA lesions and proved to be powerful
tools for investigating cellular repair systems [15]. A detailed
understanding of the mechanisms of antigen recognition of
these monoclonal antibodies is required for their further ap-
plication, especially as targets for antibody engineering aimed
to improve their a⁄nities and speci¢cities and to endow them
with catalytic activities for DNA repair.
In the previous papers, we have characterized a panel of
anti-(6-4) photoproduct antibodies, 64M2 (IgG2a,U), 64M3
(IgG2a,U), and 64M5 (IgG1,U), which were simultaneously
established from the same BALB/c mouse [10]. The variable
region genes from these antibodies have been cloned and se-
quenced [16]. It has been revealed that the sequences of the
three antibodies are closely related to one another: 64M5
shares 91% and 94% identities of amino acid sequences in
the variable regions with 64M2 and 64M3, respectively.
The binding a⁄nity of 64M5 for the DNA containing (6-4)
photoproduct is signi¢cantly higher than those of 64M2 and
64M3 [10]. It has been shown that the a⁄nity of 64M5 is
enhanced by the presence of oligonucleotides that £ank the
(6-4) adduct [17]. Similar tendencies of the a⁄nity dependence
upon the length of the DNA have been observed for other
anti-DNA antibodies [18^21]. In order to gain a deeper insight
into the mechanisms of molecular recognition of (6-4) photo-
lesions by these monoclonal antibodies, it is essential to de-
termine the binding mode of (6-4) adducts by themselves and
also to clarify the contributions of the £anking oligodeoxynu-
cleotides to their a⁄nities based on structural aspects.
It is well known that 1H-31P and 13C-31P vicinal couplings
provide us useful information on the conformation of the
deoxyribose phosphate backbone of nucleotides [22^24]. How-
ever, the line-broadening of nuclear magnetic resonances
(NMR), which are expected in the present anti-DNA antibod-
ies system with molecular weight of over 50 kDa, seriously
hampers the application of a strategy which heavily depends
upon the 1H-31P and 13C-31P couplings.
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Here, on the basis of the chemical shift and linewidth data
from 31P NMR resonances, we report the epitope analysis
results for 64M5 and 64M3. d(T[6-4]T) and d(GTAT[6-
4]TATG) were chemically synthesized and then subjected to
NMR analyses. 31P resonances originating from the individual
phosphate diesters of the backbone were assigned. On the
basis of the perturbations of the 31P chemical shift and line-
width upon binding to either the 64M5 or 64M3 Fab frag-
ment, the epitope size and locus were determined.
2. Materials and methods
2.1. Preparation of oligonucleotides containing a (6-4) photoproduct
Oligonucleotides were synthesized using a DNA synthesizer (Ap-
plied Biosystems Model 394) and puri¢ed by HPLC. 3P-Biotinylated
oligonucleotides were prepared by the same protocol on biotinylated
CPG columns (Clontech, 3PBiotin-ON CPG). Oligonucleotides con-
taining a (6-4) photoproduct were synthesized and characterized using
procedures similar to those previously described [17,25,26].
2.2. Preparation of Fab fragments
The hybridoma cells were grown in NYSF 404 (Nissui) supple-
mented with 2% heat-inactivated FBS (JRH Biosciences) at 37‡C in
a humidi¢ed atmosphere of 5% CO2/95% air. After cell growth, the
supernatant was concentrated with a Millipore Minitan ultra¢ltration
system and then applied to an A⁄-Gel protein A column (Bio-Rad).
The puri¢ed 64M5 antibody was reduced by dithiothreitol and car-
boxymethylated, and then digested by papain as previously described
[17,27]. Papain digestion of the 64M3 antibody was carried out with a
modi¢cation of our previous protocol [27,28]. The puri¢ed 64M3 (4.3
mg/ml) was incubated with papain at pH 7.0, 37‡C, in 75 mM sodium
phosphate bu¡er containing 75 mM NaCl, 2 mM EDTA, and 11 WM
cysteine for 8 h. The enzyme/substrate ratio (w/w) was 1:500. The
reaction was terminated by the addition of 33 mM N-ethylmaleimide.
Fab fragments were puri¢ed using a Mono Q anion exchange column
(Pharmacia Biotech) as previously described [28].
2.3. Determination of binding constants of 64M3 and 64M5 for
d(T[6-4]T)
For the £uorescence measurements, 64M3 and 64M5 Fab frag-
ments were dissolved at concentrations of 1.0 WM and 30 nM, respec-
tively, in 5 mM sodium phosphate bu¡er, pH 7.3, containing 200 mM
NaCl and 50 WM EDTA. Emission spectra of the protein intrinsic
£uorescence were recorded in the region of 310^350 nm upon excita-
tion at 260 nm using a Shimadzu RF-5300PC spectro£uorometer.
Excitation and emission band-passes were 5 and 10 nm, respectively.
All measurements were carried out at 30‡C. Fluorescence quenching
at 334 nm upon the addition of d(T[6-4]T) was monitored and the
binding constants of Fab for d(T[6-4]T) were determined from the
slope of the Scatchard plot [29].
2.4. Dependency of a⁄nity on ionic strength and chain length
determined by surface plasmon resonance
A⁄nity of the Fab fragments for the (6-4) photoproduct-containing
oligodeoxynucleotides was determined by surface plasmon resonance
(SPR) measurements with a BIAcore 1000 or BIAcore 2000 instru-
ment (Pharmacia Biotech) using the 3P-biotinylated d(AAT[6-4]TAA)
and d(CAAT[6-4]TAAG) as previously described [17].
2.5. NMR measurements
For the NMR measurements, 0.2^2.3 Wmol of the oligodeoxynu-
cleotides was dissolved in 450 Wl of 5 mM sodium phosphate bu¡er,
pH 7.3, containing 200 mM NaCl, 50 WM EDTA and 3 mM NaN3 in
90% 1H2O/10% 2H2O. 31P NMR measurements were made on a
Bruker AMX 400 spectrometer at 162 MHz. The probe temperature
was 37‡C. All spectra were recorded with the use of a WALTZ-16
composite pulse for 1H decoupling. The free induction decay after a
40‡ pulse was recorded with a repetition period of 5.0 s, with 16 K
data points and a spectral width of 2439 Hz. All free induction decays
were multiplied by an exponential window function with a broadening
factor of 1.0 Hz prior to the Fourier transformation. 31P chemical
shifts were given in parts per million (ppm) from the external trimeth-
yl phosphate (0.00 ppm).
All 2D NMR spectra were recorded with spectral widths of 4800 Hz
for 1H and 1000 Hz for 31P on a Bruker DRX400 spectrometer oper-
ating at 1H frequency of 400 MHz. For the double-quantum ¢ltered
correlated spectroscopy (DQF-COSY), total correlation spectros-
copy (TOCSY), and rotating frame Overhauser e¡ect spectroscopy
(ROESY) measurements, 2 K data points were used in the t2 dimen-
sion, and 16 transients were acquired for each of the 512 t1 points.
The solvent resonance was suppressed by selective irradiation during
the relaxation delay. The mixing times were set to 200 ms for TOCSY
and to 800 ms for the ROESY measurements. For the 1H-31P hetero-
nuclear single-quantum correlation (HSQC) and heteronuclear multi-
ple-bond correlation (HMBC) measurements, 2 K data points were
used in the t2 dimension, and 16 transients were acquired for each of
the 256 t1 points. The solvent resonance was suppressed by using
gradient pulses. A GARP composite pulse was used in the 1H-31P
HSQC measurements for 31P-decoupling. Prior to 2D Fourier trans-
formation, the acquired data were zero-¢lled once along the t1 direc-
tion and multiplied by a shifted sine square function in the t1 and t2
directions.
3. Results and discussion
3.1. Assignments of 31P NMR resonances
Figs. 2A and 3A show the 31P NMR spectra of d(T[6-4]T)
and d(GTAT[6-4]TATG). The 31P chemical shift of d(T[6-4]T)
(33.34 ppm) was virtually identical with that reported in the
literature [30]. On the other hand, all of the 31P resonances
originating from d(GTAT[6-4]TATG) were shifted up¢eld
(34.13 to 33.65 ppm). Assignments of the 31P resonances
were accomplished through analyses of the 1H-31P HSQC
and HMBC spectra along with DQF-COSY, TOCSY, and
ROESY spectra via a sequential assignment methodology
(spectra not shown). The established assignments of the 31P
resonances are shown in Fig. 3A, in which Pi represents the
ith phosphorus in the phosphodiester bond between the ith
and (i+1)th residues from the 5P end.
The 31P resonance originating from the (6-4) adduct (P4)
overlaps those from P2 and P6 at 34.13 ppm. Thus the 31P
chemical shift of the (6-4) adduct in d(T[6-4]T) is signi¢cantly
di¡erent from that in d(GTAT[6-4]TATG). Gorenstein and
his co-workers have extensively studied the origins of varia-
tions in the 31P chemical shifts of a variety of phosphorous
compounds including DNA oligomers [31^35]. On the basis of
the molecular orbital calculations and enormous coupling
constant data, they have concluded that the variations in
the 31P chemical shifts of individual phosphate diesters in
oligonucleotides are attributed to di¡erences in the torsional
angles (K, L, O, and j) and the O^P^O bond angle in the
deoxyribose phosphate backbone and that the ring current
e¡ects and other environmental e¡ects, such as the formation
of the hydrogen bond and salt bridge, upon the 31P chemical
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Fig. 1. Structure of d(T[6-4]T).
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shifts in the nucleic acids are generally smaller than the in-
trinsic conformational factors.
As shown in Figs. 2A and 3A, 31P resonances of the (6-4)
adduct for d(T[6-4]T) and d(GTAT[6-4]TATG) are observed
at di¡erent positions. Therefore, it is suggested that confor-
mation of the deoxyribose phosphate backbone of the (6-4)
adduct is a¡ected by the £anking oligodeoxynucleotides.
Models for the structure of d(T[6-4]T) in solution have been
built via a conformational search procedure using NMR-de-
rived distance- and angle-constraints [36]. Kim and Choi have
reported a solution structure of the DNA duplex-decamer,
d(CGCAT[6-4]TACGC)Wd(GCGTAATGCG) obtained by
NOE distance and relaxation matrix re¢nements [37]. It was
also concluded that the solution structure of the duplex-em-
bedded (6-4) adduct exhibits a very similar overall structure
compared to that of the isolated d(T[6-4]T) proposed by Tay-
lor et al [36]. However, there exist signi¢cant di¡erences in the
torsional angles of the backbone between them. It is likely
that the deoxyribose phosphate backbone of the (6-4) adduct
can take di¡erent conformations in di¡erent contexts and
those conformational di¡erences might be sensitively re£ected
in the 31P chemical shift.
3.2. Recognition of (6-4) adduct by Fab fragment
Upon the addition of either 64M5 or 64M3 Fab, the 31P
resonance of d(T[6-4]T) was slightly shifted down¢eld (Fig.
2B,C), indicating that no drastic change is induced on the
backbone conformation of d(T[6-4]T) upon binding to these
Fab fragments. Binding constants of the 64M3 and 64M5 Fab
fragments for d(T[6-4]T) determined on the basis of the £uo-
rescence quenching data were 1.8U105 M31 and 5.9U107
M31, respectively. A signi¢cant broadness of the 31P reso-
nance was observed for the 64M3 Fab complex probably
due to a faster exchange process between the free and bound
forms which was a result of the lower a⁄nity of 64M3 for
d(T[6-4]T) than that of 64M5.
On the other hand, all but P1 and P7 resonances originating
from d(GTAT[6-4]TATG) were perturbed both in chemical
shift and linewidth upon the addition of 64M5 Fab (Fig.
3B). This result indicates that the segment spanning P2^P6
is involved in the binding to 64M5 Fab but both of the 5P-
and 3P-terminal nucleotides are not. Though the identi¢cation
of the 31P resonance (P4) from the (6-4) adduct of d(GTAT[6-
4]TATG) in the 64M3 and 64M5 complexes is di⁄cult due to
incidental spectral overlaps and line-broadening, there is no
doubt that no resonance is observed in Fig. 3B,C around the
position corresponding to those of d(T[6-4]T) complexed with
the Fab fragments (ca. 33 ppm). This observation indicates
that the chemical shift of the (6-4) adduct in both the 64M3
and 64M5 complexes is quite di¡erent between d(T[6-4]T) and
d(GTAT[6-4]TATG). On the basis of these results, it is con-
cluded that (i) the backbone of the (6-4) adduct of d(T[6-4]T)
in the complex takes a di¡erent conformation from that of the
bound d(GTAT[6-4]TATG), and (ii) the (6-4) adducts with an
altered backbone conformation can be accommodated in the
antibody-combining sites of 64M3 and 64M5, probably due to
the £exible nature of the combining sites of these antibodies.
The antibodies used in the present study recognize d(T[6-
4]T) embedded in either the single- or double-stranded DNA
[10,17]. Zhao and Taylor [13] have established monoclonal
antibodies elicited by the isolated d(T[6-4]T) and showed
that these antibodies are capable of binding to d(T[6-4]T)
embedded in DNA. On the basis of these results, they have
suggested that some of the conformational states of the d(T[6-
4]T) in the dinucleotide and DNA are rather similar. How-
ever, the present NMR data indicate that the backbone con-
formation of d(T[6-4]T) can at least be altered by the presence
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Fig. 3. 31P NMR spectra of d(GTAT[6-4]TATG) in the absence (A)
and presence (B,C) of 1.1 molar equivalent of Fab (B: 64M5 Fab
and C: 64M3 Fab). The concentrations of d(T[6-4]T) were (A) 3.5
mM, (B,C) 0.4 mM. Pi represents the ith phosphorus in the phos-
phodiester bond between the ith and (i+1)th residues from the 5P
end.
Fig. 2. 31P NMR spectra of d(T[6-4]T) in the absence (A) and pres-
ence (B,C) of 0.5 molar equivalent of Fab (B: 64M5 Fab and C:
64M3 Fab). The concentrations of d(T[6-4]T) were (A) 4.5 mM and
(B,C) 1.0 mM. In B and C, 31P resonances originating from the
Fab-bound forms of d(T[6-4]T) are indicated by asterisks.
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of the £anking sequences. We therefore point out that the
conformational conservativeness of the (6-4) adduct probed
by antibodies must be carefully interpreted because anti-
body-combining sites might adapt themselves to the (6-4) ad-
ducts exhibiting di¡erent conformations.
3.3. Contributions of the £anking oligodeoxynucleotides to
antigen-antibody interactions
The results obtained in the present study showing that the
regions containing P2, P3, P5, and P6 are also involved in the
Fab binding are very consistent with our previous data that
the dissociation rate constants (Kdiss) of 64M5 Fab for d(T[6-
4]T)-containing oligodeoxynucleotides are dependent upon the
length of the sequences £anking the (6-4) adduct; longer oli-
godeoxynucleotides up to d6mer indicate a smaller Kdiss, but
the Kdiss for the d8mer is virtually identical to that of the
d6mer [17].
In a number of DNA-protein recognition systems, ‘non-
speci¢c’ electrostatic interactions signi¢cantly contribute to
the binding a⁄nities [38,39]. The contribution of electrostatic
interactions has been proved or postulated for a variety of
DNA-anti-DNA antibody systems [40^45]. On the basis of
the results from the SPR measurement in the present study,
it is concluded that the binding constant of 64M5 for the
d8mer is strongly dependent upon ionic strength, i.e.
9.3U109 M31 and 9.2U108 M31 at NaCl concentrations of
10 mM and 1 M, respectively. We therefore suggest that the
£anking region of the oligodeoxynucleotide containing the (6-
4) adduct contributes to the binding to 64M3 and 64M5
through electrostatic interactions between the phosphate
groups and basic amino acid side chains.
A signi¢cant up¢eld shifted resonance at 34.80 ppm is
observed in the 31P spectrum of d(GTAT[6-4]TATG) in the
presence of 64M5 Fab (Fig. 3B), suggesting that torsional
angles in the deoxyribose phosphate backbone in the £anking
regions are altered upon binding to 64M5 Fab. Binding to
64M3 Fab also induced a chemical shift and linewidth
changes for P2 to P6 resonances but the positions of the
perturbed resonances were apparently di¡erent from those
of 64M5 (Fig. 3C): the most remarkable example is the up-
¢eld peak at 34.80 ppm in the spectrum of the complex with
64M5 Fab (Fig. 2B), which is not observed for the complex
with 64M3 Fab (Fig. 2C). In addition, binding to 64M3 Fab
induced line-broadening of the P1 resonance, indicating that
the 5P-terminal nucleotide is more restricted in motion in the
complex with 64M3 than in the 64M5 complex. This indicates
that (i) the backbone conformations of the £anking regions
are di¡erent between the complexes with 64M3 and 64M5
Fab fragments, and (ii) the £anking region of the 5P side is
more extensively involved in 64M3 binding than in the case of
64M5 binding. The latter was supported by the data obtained
from the SPR experiment showing that Kdiss of 64M3 Fab for
a d(T[6-4]T)-containing d8mer is still signi¢cantly smaller than
that for the corresponding d6mer; the Kdiss for d8mer is
6.5U1034 s31 and the Kdiss for d6mer is 1.6U1033 s31. On
the basis of these data, we conclude that the contribution of
non-speci¢c interactions with the £anking oligodeoxynucleo-
tides can be more signi¢cant for 64M3 Fab than for 64M5
Fab, while the a⁄nity of 64M5 Fab for the (6-4) adduct in
itself is much stronger than that of 64M3 Fab.
Although 64M5 and 64M3 share amino acid identities of
90% for the VH and 97% for the VL, there are three positions
where substitution of a charged residue occurs: positions 99H,
50L, and 90L are occupied by Ser, Thr, and Arg in 64M5
respectively, whereas by Lys, Lys, and Gln in 64M3, respec-
tively [16]. We suggest that di¡erences in the charge distribu-
tion in the antibody-combining site between 64M3 and 64M5
result in a di¡erent fashion of stabilization of the £anking
oligodeoxynucleotides. It is possible that the additional pos-
itive charges at 99H and/or 50L in 64M3 contribute to the
interaction with the P1 phosphate group rendering the d8mer
more stabilized in the complex than the d6mer. A stable-iso-
tope-assisted NMR study has revealed that Ser-99H and Thr-
50L are located in a peripheral region surrounding the (6-4)
adduct-binding site of 64M5 Fab (manuscript in preparation).
We propose that one possible way to achieve improvement of
the a⁄nity of 64M5 for antigenic DNA oligomers longer than
d8mer is to introduce a basic amino acid residue at positions
50L and/or 99H.
The present 31P NMR study has shown that epitopes for
the 64M5 and 64M3 antibodies are constructed not only from
the (6-4) adduct but also from the £anking di- or tri-deoxy-
nucleotides on both the 5P and 3P sides. If the antigenic single-
stranded DNA is bound to the antibodies in an extended
form, the epitope sizes are obviously larger than that of anti-
gen-combining sites so far reported for a variety of antigen-
antibody systems [46]. In order to gain more knowledge on
the binding mechanisms of these antibodies, it is necessary to
obtain structural information on the antibody combining sites
of these antibodies. NMR analyses using isotopically labeled
Fab fragments of 64M3 and 64M5 are underway in our labo-
ratory.
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